Laparoscopic management of women with a family history of ovarian cancer

Journal of Surgical Oncology

Volumn 72, Issue 1, 1999, Pages 9-13

  Eltabbakh, Gamal H ^a   Piver, M Steven ^b   Hempling, Ronald E ^b   Recio, Fernando O ^b   Paczos, Tamera ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Familial ovarian cancer; Laparoscopy; Prophylactic oophorectomy

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LAPAROTOMY; MAJOR CLINICAL STUDY; OVARIECTOMY; OVARY CARCINOMA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL RISK; SURGICAL TECHNIQUE;

ADULT; AGED; BRCA2 PROTEIN; FEASIBILITY STUDIES; FEMALE; GENES, BRCA1; HUMANS; HYSTERECTOMY; LAPAROSCOPY; MEDICAL HISTORY TAKING; MENOPAUSE; MIDDLE AGED; MORBIDITY; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OVARIECTOMY; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; TRANSCRIPTION FACTORS;

EID: 0032832632     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199909)72:1<9::AID-JSO3>3.0.CO;2-7     Document Type: Article

References (14)

1. Crawford RA, Gore ME, Sheperd JH: Ovarian cancers related to minimal access surgery. Br J Obstet Gynecol 1995;102:726-730.
2. Goldberg JM, Piver MS, Jishi MF, Blumenson L: Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Gynecol Oncol 1997;66:3-9.
3. Piver MS, Jishi MF, Tsukada Y, Nava G: Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993;71:2751-2755.
4. Bush TL, Coway LD, Barrett-Connor E, et al.: Estrogen use and all-cause mortality. Preliminary results from the lipid research clinic follow-up study. JAMA 1983;249:903-906.
5. Eltabbakh GH, Piver MS, Hempling RE, et al.: Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer. Gynecol Oncol 1997;66:103-107.
6. Hidlebaugh DA, Vulgaropulos S, Orr RK: Treating adnexal masses. Operative laparoscopy vs. laparotomy. J Reprod Med 1997;42:551-558.
7. Yuen PM, Yu KM, Yip SK, et al.: A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 1997;77:109-114.
8. Shalev E, Elyahu S, Peleg D, Tsabari A: Laparoscopic management of adnexal cystic masses in postmenopausal women. Obstet Gynecol 1994;83:594-596.
9. Mirhashemi R, Harlow BL, Ginsburg ES, et al.: Predicting risk of complications with gynecologic laparoscopic surgery. Obstet Gynecol 1998;92:327-331.
10. Menczer J, Dan U, Oelsner G: Laparoscopic prophylactic oophorectomy in women belonging to ovarian cancer-prone families. Advantages and shortcomings. Eur J Gynecol Oncol 1994;15: 105-107.
11. Boyd J, Rubin SC: Hereditary ovarian cancer: molecular genetics and clinical implications. Gynecol Oncol 1997;64:196-206.
12. Grann VR, Panageas KS, Ahang W, et al.: Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol 1998;16:979-985.
13. Schrag D, Kuntz KM, Garber JE, Weeks JC: Decision analysis: effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336:1465-1471.
14. Werness BA, Afify AM, Bielat KL, et al.: Altered surface epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol 1999;30:151-157.